The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

stratosgenomics.com

Total Raised

$53.2M

Investors Count

5

Deal Terms

2

Stratos Genomics Funding, Stratos Genomics Valuation & Stratos Genomics Revenue

8 Fundings

Stratos Genomics's latest funding round was a Acquired for on May 22, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/22/2020

Acquired

0

FY undefined

4

1/8/2018

Series C

$99M

0

FY undefined

10

6/16/2015

Series B - III

$99M

0

FY undefined

10

6/26/2014

Corporate Minority

$99M

0

FY undefined

10

9/6/2013

Series B - II

$99M

0

FY undefined

10

Date

5/22/2020

1/8/2018

6/16/2015

6/26/2014

9/6/2013

Round

Acquired

Series C

Series B - III

Corporate Minority

Series B - II

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

4

10

10

10

10

Stratos Genomics Deal Terms

2 Deal Terms

Stratos Genomics's deal structure is available for 2 funding rounds, including their Series B from October 16, 2012.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Stratos Genomics Investors

5 Investors

Stratos Genomics has 5 investors. Roche Holding invested in Stratos Genomics's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/26/2014

5/22/2020

2
Corporate Minority, Acquired (2020)

Holding Company

Switzerland

00/00/0000

00/00/0000

Fisk Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Roche Venture Fund

Subscribe to see more

Corporate Venture

Switzerland

00/00/0000

00/00/0000

SV Health Investors

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Stratos Group

Subscribe to see more

Subscribe to see more

Other

New Jersey

First funding

6/26/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

5/22/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Fisk Ventures

Roche Venture Fund

SV Health Investors

Stratos Group

Rounds

2
Corporate Minority, Acquired (2020)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Holding Company

Venture Capital

Corporate Venture

Venture Capital

Other

Location

Switzerland

New York

Switzerland

Massachusetts

New Jersey

You May Also Like

A
ACGT

ACGT develops genomics-based solutions that increase productivity and enhance value creation from the oil palm and other oil crops. It is based in Kuala Lumpur, Malaysia.

Omixon Logo
Omixon

Omixon is a global molecular diagnostics company that commercializes technologies for clinical and research laboratories. Omixon's flagship product, Holotype HLA, is an NGS-based HLA genotyping product that delivers high-resolution HLA genotyping. Omixon's research software, HLA Explore, analyzes data from any sequencing technology and determines HLA genotypes from whole exome/genome sequencing experiments.

Aperiomics Logo
Aperiomics

Aperiomics identifies bacteria, viruses, fungi, and parasites through Deep Shotgun Metagenomic Sequencing, using its database of microbes. The company helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.

S
Sequentia Biotech

Sequentia Biotech is a bioinformatics company that transforms omics data into knowledge. The company offers bioinformatics cloud softwares, custom softwares and bioinformatics consulting services for healthcare, pharma, agriculture, industry and the environment.

CJ Bioscience Logo
CJ Bioscience

CJ Bioscience (KOSDAQ: 311690) is a bioinformatics company that develops data-driven microbiome therapeutics solutions for the microbiology sector. The company's suite of tools includes EzBioCloud, a database for academic research and commercial development, and BIOiPLUG, a cloud-based bioinformatics and analysis platform. It was founded in 2009 and is based in Seoul, South Korea.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.